| Serial Number | 99044353 |
| Word Mark | ESTEVE PHARMACEUTICALS |
| Filing Date | Monday, February 17, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, November 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 25, 2025 |
| Goods and Services | Pharmaceutical preparations for the treatment of metabolic disorders, namely, for treating diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of the endocrine system, namely, for treating growth and thyroid disorders; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, for treating connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, for treating urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, for use in treating Alzheimer's disease, Huntington's disease, cerebral palsy, brain injuries, spinal cord injuries, and seizure disorders; Pharmaceutical preparations for the treatment of hormonal disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, for treating mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology, namely, for use in treating dermatitis, eczema, psoriasis, skin pigmentation diseases, and dermatological sexually transmitted diseases |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 17, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ESTEVE PHARMACEUTICALS, S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 85 - NOT AVAILABLE |
| Address | Barcelona 08038 ES |
| Event Date | Event Description |
| Monday, February 17, 2025 | NEW APPLICATION ENTERED |
| Monday, February 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 17, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 23, 2025 | ASSIGNED TO EXAMINER |
| Saturday, July 26, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, July 26, 2025 | NON-FINAL ACTION E-MAILED |
| Saturday, July 26, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 27, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, October 27, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, October 27, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, October 27, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, October 27, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |